Search
for
Sort by
Research 20
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- Comment on ‘Androgenetic alopecia is associated with increased scalp hardness’: role of phosphodiesterase inhibitors?
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- A novel therapeutic paradigm for patients with extensive alopecia areata
- New drugs under investigation for the treatment of alopecias
- Novel therapies for alopecia areata: The era of rational drug development
- Emerging smart microneedle technologies in psoriasis: convergence of nanocarriers, machine learning, and personalized delivery
- Clinical manifestations of polycystic ovary syndrome
- Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectives – A review